| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
1 |
| mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
1 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |
| mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |